Cargando…
Measles Virus as an Oncolytic Immunotherapy
SIMPLE SUMMARY: Measles virus is currently under investigation as an innovative cancer treatment. The virus selectively replicates in and kills cancer cells. Furthermore, it can be genetically engineered to increase tumor specificity and therapeutic efficacy. Importantly, treatment with measles viru...
Autores principales: | Engeland, Christine E., Ungerechts, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867054/ https://www.ncbi.nlm.nih.gov/pubmed/33535479 http://dx.doi.org/10.3390/cancers13030544 |
Ejemplares similares
-
Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference †
por: Anker, Sophie C., et al.
Publicado: (2023) -
MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer
por: Singh, Hans Martin, et al.
Publicado: (2021) -
Engineering and combining oncolytic measles virus for cancer therapy
por: Leber, Mathias F., et al.
Publicado: (2020) -
Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites
por: Leber, Mathias Felix, et al.
Publicado: (2018) -
Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory
por: Veinalde, Rūta, et al.
Publicado: (2021)